title: Efflorescence of scalp cysts during vemurafenib treatment following brain radiation therapy: a radiation recall dermatitis?
authors.affiliation: Department of Dermatology.
authors.forename: Marie
authors.initials: M
authors.lastname: Reigneau
authors.forename: Florence
authors.initials: F
authors.lastname: Granel-Brocard
authors.forename: Lionnel
authors.initials: L
authors.lastname: Geoffrois
authors.forename: Anne-Sophie
authors.initials: AS
authors.lastname: Bauman
authors.forename: Philippe
authors.initials: P
authors.lastname: Tréchot
authors.forename: Annick
authors.initials: A
authors.lastname: Barbaud
authors.forename: Jean-Luc
authors.initials: JL
authors.lastname: Schmutz
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy / Q000556:secondary; D003560:Cysts / Q000139:chemically induced* / Q000188:drug therapy / Q000473:pathology; D019583:Dose Fractionation, Radiation; D005546:Forehead; D006801:Humans; D007211:Indoles / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D008545:Melanoma / Q000188:drug therapy* / Q000532:radiotherapy / Q000556:secondary; D008875:Middle Aged; D011855:Radiodermatitis / Q000139:chemically induced*; D012535:Scalp; D012878:Skin Neoplasms / Q000473:pathology* / Q000628:therapy; D013449:Sulfonamides / Q000008:administration & dosage / Q000009:adverse effects*; D000077484:Vemurafenib
chemical_list: D000970:Antineoplastic Agents; D007211:Indoles; D013449:Sulfonamides; D000077484:Vemurafenib